单位:[1]“De Gasperis” Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy[2]Department of Health Sciences, University of Milano-Bicocca, Monza, Italy[3]Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China华中科技大学同济医学院附属同济医院[4]Cardiopathology, Institute for Pathology, University Hospital of Tübingen, Tübingen, Germany[5]Sakakibara Heart Institute, Tokyo, Japan[6]Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan[7]Mais Philipps University of Marburg, Faculty of Medicine, Marburg, Germany[8]Henan Provincial People's Hospital, Zhengzhou, China[9]Department of Cardiology, Campus Virchow and Berlin Institute of Health, Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Germany[10]Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA
Fulminant myocarditis (FM) is a form of acute myocardial inflammation leading to rapid-onset hemodynamic instability due to cardiogenic shock or life-threatening arrhythmias. As highlighted by recent registries, FM is associated with high rates of death and heart transplantation, regardless of the underlying histology. Because of a paucity of evidence-based management strategies exists for this disease, an International workshop on FM was held in Wuhan, China, in October 2019, in order to share knowledge on the disease and identify areas of consensus. The present report highlights both agreements and controversies in FM management across the world, focusing the attention on areas of opportunity, FM definition, the use of endomyocardial biopsy and viral identification on heart specimens, treatment algorithms including immunosuppression and the timing of circulatory support escalation. This report incorporates the most recent recommendations from national and international professional societies. Main areas of interest and aims of future prospective observational registries and randomized controlled trials were finally identified and suggested. (C) 2020 Elsevier B.V. All rights reserved.
基金:
Tongji Hospital Clinical Research Flagship Program [2019CR207]
第一作者单位:[1]“De Gasperis” Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy[2]Department of Health Sciences, University of Milano-Bicocca, Monza, Italy
共同第一作者:
通讯作者:
通讯机构:[3]Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China[*1]“De Gasperis” Cardio Center,ASST Grande Ospedale Metropolitano Niguarda,Piazza Ospedale Maggiore,3; 20162,Milan,Italy.[*2]Division of Cardiology,Department of Internal Medicine,Tongji Hospital,Tongji Medical College,Huazhong University of Science & Technology 1095# Jiefang Ave.,Wuhan 430030
推荐引用方式(GB/T 7714):
veronese giacomo,ammirati enrico,chen chen,et al.Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis[J].INTERNATIONAL JOURNAL OF CARDIOLOGY.2021,324:131-138.doi:10.1016/j.ijcard.2020.10.063.
APA:
veronese,giacomo,ammirati,enrico,chen,chen,klingel,karin,suzuki,makoto...&wang,dao wen.(2021).Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis.INTERNATIONAL JOURNAL OF CARDIOLOGY,324,
MLA:
veronese,giacomo,et al."Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis".INTERNATIONAL JOURNAL OF CARDIOLOGY 324.(2021):131-138